<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cytogenetic information in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is important in predicting prognosis and therapeutic direction </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, the detection of numerical type abnormalities, either whole chromosome or partial chromosomal segments, is important </plain></SENT>
<SENT sid="2" pm="."><plain>In general, conventional banding chromosome analysis is useful in detecting chromosome changes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and is able to predict prognosis </plain></SENT>
<SENT sid="3" pm="."><plain>More recently, <z:mp ids='MP_0008867'>uniparental disomy</z:mp> at various loci has been found in some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients and target genes located within the deleted chromosome regions; these deletions are either cytogenetically detectable resulting in partial <z:mp ids='MP_0004026'>monosomy</z:mp>, or cryptic </plain></SENT>
<SENT sid="4" pm="."><plain>Further therapeutic approaches for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients may require more precise cytogenetic information in the near future </plain></SENT>
</text></document>